Key Highlights
- Third-quarter 2026 Revenue was USD 7.34 million, up 75% from USD 4.19 million, as the company sold 15 breast acoustic CT scanners versus 9 a year earlier; nine-month revenue reached USD 21.3 million.
- Management lowered its full-year 2026 revenue outlook to approximately USD 34 million from about USD 39 million, citing shipment delays to distribution partners in Saudi Arabia and the United Arab Emirates.
- The net loss was USD 297,000, or USD 0.02 per share, versus USD 4.6 million, or USD 0.47, helped by a USD 2.4 million non-cash gain on an earn-out liability.
- Cash, equivalents and restricted cash were about USD 8.4 million at September 30, 2026, down from about USD 11.0 million at June 30, with USD 2.2 million used in operations in the quarter.
Scanner Volume Lifts Revenue, but Middle East Shipments Slip
QT Imaging Holdings (NASDAQ:QTI), which makes a radiation-free breast acoustic CT scanner, filed its Quarterly Report on November 10, 2026 and held its call the same day. Revenue was USD 7.34 million and Gross Profit was USD 3.03 million, a 41.3% gross margin. For the nine months, the company sold 43 scanners and revenue was USD 21.3 million versus USD 10.7 million. The CFO cut the 2026 revenue outlook to roughly USD 34 million because the conflict in the Middle East disrupted shipping routes and delayed deliveries to partners in Saudi Arabia and the United Arab Emirates. The U.S. scanner shipment plan is unchanged, and management would not commit to a Middle East shipment date.
Smaller Net Loss Comes From a Non-Cash Earn-Out Swing
Operating loss widened to USD 2.4 million from USD 1.7 million as operating expenses rose to USD 5.5 million from USD 3.5 million. Research and Development was USD 1.7 million and selling, general and administrative expense was USD 3.8 million, reflecting added commercial staff and clinical work. The net loss narrowed to USD 297,000 only because the change in Fair Value of the earn-out Liability produced a USD 2.4 million gain, against a USD 2.2 million expense a year earlier. Nine-month net loss was USD 14.8 million, or USD 0.99 per share, versus USD 19.7 million, or USD 2.09. The nine-month figure includes a USD 8.3 million loss on Debt extinguishment and modification.
Medicare Payment Win, Distribution Talks and Thin Cash
On November 4, 2026 the Centers for Medicare and Medicaid Services set a separate hospital outpatient payment for diagnostic QT scan exams effective January 1, 2027, reversing an earlier proposed non-payment decision, according to management. The U.S. distribution agreement with NXT Imaging, a Canon Medical Systems USA subsidiary, runs through year-end and a new agreement has not been finalized. A group purchasing agreement covering nearly 4,400 hospitals was secured in October. With the outlook cut, implied fourth-quarter revenue is about USD 12.7 million (calculated: USD 34 million less USD 21.3 million), so delivery matters. Cash of USD 8.4 million against USD 10.7 million used in operations over nine months is a constraint to watch.
Where Things Stand
Because delays in Middle East shipments, not weak U.S. demand, hit timing, according to management. QT Imaging Holdings (NASDAQ:QTI) lowered its 2026 revenue view to about USD 34 million from USD 39 million even as third-quarter revenue grew 75%. The smaller loss relied on a non-cash earn-out gain, cash fell to USD 8.4 million, and the distribution agreement is unsettled. The reimbursement decision effective January 1, 2027, scanner deliveries and a new distribution deal are the next markers.






Please wait processing your request...